National Institute of Mental Health and Neurosciences (NIMHANS), Department of Psychiatry NIMHANS, 560029, Bangalore, Karnataka, India.
National Institute of Mental Health and Neurosciences (NIMHANS), Department of Psychiatry NIMHANS, 560029, Bangalore, Karnataka, India.
Asian J Psychiatr. 2019 Jun;43:87-90. doi: 10.1016/j.ajp.2019.05.015. Epub 2019 May 7.
Obsessive-compulsive disorder (OCD) with comorbid bipolar affective disorder (BPAD) is often faced with a therapeutic challenge. Pharmacological treatment strategy engaged towards alleviating symptoms in OCD has the propensity to precipitate a manic switch in patients with comorbid BPAD. Advanced non-invasive brain stimulation techniques like high definition transcranial direct current stimulation (HD-tDCS) may target the symptoms of OCD while preventing a probable manic switch in a vulnerable population. In this case series, we targeted OC symptoms in three patients by giving 2 mA of anodal HD-tDCS at their pre-SMA (localized using 10/10 EEG system) with 4 surrounding return electrodes of opposite polarity for 20 min of two sessions having an intersession gap of 20 min receiving a maximum of 20 sessions. We found that the patients showed significant improvement (more than 25%) in their OC symptoms while having no affective side effects and this effect was replicated in one of the two patients in repeating the treatment for relapse. This case series highlights the efficacy and durability of the effect of HD-tDCS as an add-on treatment modality in three patients who were treated for OC symptoms in the context of a comorbid bipolar disorder, two of them receiving repeat courses on relapse.
伴有共病双相情感障碍(BPAD)的强迫症(OCD)常常面临治疗挑战。针对 OCD 症状缓解的药物治疗策略可能会导致共病 BPAD 患者出现躁狂发作。高级非侵入性脑刺激技术,如高清晰度经颅直流电刺激(HD-tDCS),可以针对 OCD 症状,同时预防易感人群中可能出现的躁狂发作。在本病例系列中,我们通过在患者的前 SMA 给予 2 mA 的阳极 HD-tDCS(使用 10/10 EEG 系统定位),并用相反极性的 4 个周围返回电极,每次治疗 20 分钟,两次治疗之间间隔 20 分钟,最多可进行 20 次治疗,针对 3 名患者的 OC 症状进行治疗。我们发现,患者的 OC 症状显著改善(超过 25%),而没有情感副作用,其中 2 名患者在复发时重复治疗,这种效果得到了复制。本病例系列强调了 HD-tDCS 作为一种附加治疗方式的疗效和持久性,该治疗方式针对共病双相情感障碍的 3 名患者的 OC 症状进行治疗,其中 2 名患者在复发时接受了重复疗程。